Mendus (OMX: IMMU)

Last close As at 07/03/2025

SEK7.55

0.05 (0.67%)

Market capitalisation

SEK381m

Mendus is a clinical-stage immunoncology (IO) company based in Sweden and the Netherlands. The company specialises in allogeneic dendritic cell biology and currently has two lead, cell-based, off-the-shelf therapies for haematological and solid tumours.

Latest Insights

View More

Healthcare | Flash

Mendus — CADENCE trial enrols first patient

Healthcare | Update

Mendus — Vididencel on track in AML going into 2025

Healthcare | Flash

Mendus — Focus firmly on pivotal-stage readiness in 2025

Mendus_resized

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Alex Karlsson-Parra

    CSO

  • Erik Manting

    CEO

  • Jeroen Rovers

    CMO

  • Leopold Bertea

    CTO

  • Lotta Ferm

    CFO

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free